• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-08-11

  This guide explains how to use Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 for HMGB1 detection in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. It is intended for controlled research workflows only; no directly matched paper evidence or diagnostic, therapeutic, or medical-use validation is supplied.

• Novel Allosteric PDK4 Inhibitors in Metabolic Disease

  2026-08-11

  The 2019 Journal of Medicinal Chemistry study identified anthraquinone-derived allosteric pyruvate dehydrogenase kinase 4 inhibitors, with compound 8c showing an in vitro IC50 of 84 nM. Its metabolic stability, pharmacokinetic behavior, and activity in diet-induced obesity, allergy, and cancer-related models support further investigation of PDK4-directed PDH activation, while remaining preclinical evidence.

• BMS 599626: EGFR/HER2 to Senescence

  2026-08-10

  A translational framework for using BMS 599626 dihydrochloride to interrogate EGFR/HER2 signaling, cancer cell proliferation, xenograft response, and carefully defined links to senescence research.

• Metal-Chelating L-Phe Nanostructures Reprogram Tumor Immunit

  2026-08-09

  A 2024 Nature Nanotechnology study shows that Mg2+-, Fe2+-, or Zn2+-chelating L-phenylalanine nanostructures can activate dendritic cells by coupling ion-channel regulation to NF-κB and NLRP3 signaling. When combined with short-term starvation, this approach remodels the immunosuppressive tumor microenvironment and improves breast-tumor sensitivity to immune checkpoint blockade.

• Wnt–EGFR Control of DNA Damage Responses in Drosophila

  2026-08-08

  Ewen-Campen and Perrimon developed an in vivo genetic system to induce reproducible DNA double-strand damage in the Drosophila wing imaginal disc and used it to define a Wg–Rhomboid–EGFR survival circuit. Their results show that canonical Wnt signaling can alter the apoptotic consequence of DNA damage through Chk2-, p53-, and E2F1-dependent mechanisms, offering a framework for studying tissue-specific damage sensitivity.

• Trelagliptin Protects Chondrocytes via AMPK/SOX-9

  2026-08-07

  The reference study identifies Trelagliptin as a protective modulator of IL-1β-injured human chondrocytes, linking its effects to restoration of AMPK activity and SOX-9 expression. Its findings extend investigation of this diabetes drug beyond glucose control while also defining important limits for translation to osteoarthritis models.

• Poly(I:C): Synthetic dsRNA Analog and Benchmark TLR3 Agonist

  2026-08-07

  Poly(I:C), a synthetic double-stranded RNA analog, is a potent TLR3 agonist and interferon inducer widely used in immunology research. It robustly stimulates dendritic cell maturation and innate immune responses, serving as a gold-standard tool for modeling antiviral immunity.

• Pterostilbene Enhances Mitophagy to Delay Dermal Fibroblast

  2026-08-06

  Zhou et al. (2025) demonstrate that pterostilbene counters cellular aging in human dermal fibroblasts by restoring mitochondrial quality through the promotion of mitophagy. This mechanistic insight highlights a promising strategy for mitigating both intrinsic and extrinsic skin aging at the cellular level.

• PCMT1 Drives Ovarian Cancer Metastasis via Anoikis Resistanc

  2026-08-06

  Zhang et al. employed a genome-wide CRISPR/Cas9 knockout screen to systematically uncover PCMT1 as a critical regulator of anoikis resistance and metastasis in ovarian cancer. Their findings reveal a mechanistic link between PCMT1, ECM remodeling, and integrin-FAK-Src signaling, highlighting new therapeutic avenues and experimental models for metastatic disease.

• Triazole ALDH2 Activators: New Frontiers in Myocardial Prote

  2026-08-05

  This article reviews the innovation and mechanistic findings of a recent study on novel triazole-based aldehyde dehydrogenase 2 (ALDH2) activators for myocardial ischemia-reperfusion injury. The study demonstrates that these small molecules, especially compound Z17, significantly enhance ALDH2 activity and confer robust cardioprotection in preclinical models, addressing a critical gap in myocardial infarction therapeutics.

• Taltirelin Acetate: Translational Mechanisms and Next-Genera

  2026-08-05

  Explore the unique neuroprotective mechanisms of Taltirelin acetate, a long-acting TRH analog, with cutting-edge insights into its role in Parkinson’s disease research and beyond. This in-depth article unlocks new translational directions and protocol innovations for preclinical neuroscience.

• Mouse Tissue Lysis Kit (K1038): Workflow and Protocol Guide

  2026-08-04

  The Mouse Tissue Lysis Kit (K1038) enables rapid and direct lysis of mouse tissues, streamlining DNA preparation for genotyping assays in molecular biology research. This kit is not suitable for diagnostic or clinical applications and should only be used for scientific research workflows.

• HyperScribe™ Poly (A) Tailing Kit: Precision in mRNA Stabili

  2026-08-04

  The HyperScribe™ Poly (A) Tailing Kit leverages E. coli Poly (A) Polymerase to deliver robust, reproducible polyadenylation for mRNA stability enhancement and translation efficiency improvement. This kit uniquely enables seamless integration into advanced gene expression workflows, providing researchers with actionable protocol optimizations and troubleshooting strategies for high-yield, application-ready RNA.

• HIF-1–Induced tiRNA-Lys-CTT-003 Protects Renal Tubules from

  2026-08-03

  This study identifies a novel mechanism by which HIF-1α-induced tiRNA-Lys-CTT-003 protects renal tubular epithelial cells from cisplatin-induced ferroptosis in acute kidney injury (AKI). The data reveal that tiRNA-Lys acts through interaction with GRSF1 to upregulate GPX4, thereby limiting ferroptotic cell death and improving renal function.

• Tomivosertib Suppresses Spontaneous Activity in Human DRG Ne

  2026-08-03

  This study provides the first direct evidence that tomivosertib, a selective MNK inhibitor, rapidly and reversibly suppresses spontaneous activity in human dorsal root ganglion neurons from radiculopathy patients. The findings highlight MNK signaling as a central driver of neuropathic pain and suggest MNK inhibition as a promising translational target for pain therapeutics.

15790 records 1/1053 page Next 12345 下5页 Last page